First-in-class drug tested in patients with advanced cancer; targets stem-like properties of certain cancer cells
Tuesday, April 20, 2010 - 23:11
in Health & Medicine
Researchers are working to develop a novel first-in-class cancer drug that works by targeting the stem-like properties of some cancer cells, and so far, results of an ongoing Phase I clinical trial demonstrate early signs of a strong safety profile and clinical activity.